Provided by Tiger Trade Technology Pte. Ltd.

Labcorp Holdings Inc

311.54
+4.581.49%
Post-market: 311.540.00000.00%19:30 EDT
Volume:809.93K
Turnover:250.38M
Market Cap:25.20B
PE:25.80
High:312.20
Open:310.54
Low:305.72
Close:306.96
52wk High:341.80
52wk Low:244.52
Shares:80.90M
Float Shares:80.50M
Volume Ratio:1.07
T/O Rate:1.01%
Dividend:2.88
Dividend Rate:0.92%
EPS(TTM):12.08
EPS(LYR):10.46
ROE:11.73%
ROA:5.53%
PB:2.93
PE(LYR):29.78

Loading ...

Labcorp Keeps Quarterly Dividend at $0.72 a Share, Payable Sept. 11 to Holders of Record Aug. 28

MT Newswires Live
·
Jul 10

Labcorp Declares Quarterly Dividend

THOMSON REUTERS
·
Jul 10

Labcorp Holdings Inc. Stock Underperforms Wednesday When Compared to Competitors

Dow Jones
·
Jul 09

Evercore ISI Adjusts Price Target on Labcorp to $315 From $300

MT Newswires Live
·
Jul 07

Labcorp EVP, Diagnostics President Bryan T. Vaughn Disposes of Common Shares Worth $93,769.74

Reuters
·
Jul 06

Labcorp Holdings (LH) Expands Cancer And Liver Testing, Is It Fully Priced?

Simply Wall St.
·
Jul 06

Why Labcorp Holdings (LH) Is Up 7.7% After Expanding Advanced At-Home and Blood-Based Diagnostics

Simply Wall St.
·
Jul 03

Genfit, Labcorp Secure Medicare Coverage for Nashnext MASH Blood Test Under License Deal

Reuters
·
Jul 03

Labcorp Holdings Inc. Stock Underperforms Wednesday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Jul 02

Labcorp to Report Q2 Results, Host Webcast Update

Reuters
·
Jul 01

Labcorp to Announce Second Quarter 2026 Financial Results on July 30, 2026

THOMSON REUTERS
·
Jul 01

Labcorp Holdings Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jun 30

Labcorp Holdings Inc. Stock Underperforms Friday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Jun 27

Fortrea Slips After New CFO Appointment

Reuters
·
Jun 26

Does Labcorp’s New RNA At‑Home ColoSense Screening Win Shift The Bull Case For LH?

Simply Wall St.
·
Jun 24

Labcorp Holdings Inc. Stock Underperforms Tuesday When Compared To Competitors Despite Daily Gains

Dow Jones
·
Jun 24

Labcorp Says ColoSense Colorectal Cancer Screening Test Available Nationwide

MT Newswires Live
·
Jun 22

Labcorp Announces Nationwide Availability of Colosense®, the First FDA-Approved Rna-Based at-Home Colorectal Cancer Screening Test

THOMSON REUTERS
·
Jun 22

Labcorp Holdings Inc. Stock Outperforms Competitors Despite Losses On The Day

Dow Jones
·
Jun 19

Labcorp Holdings Inc. Stock Outperforms Competitors Despite Losses On The Day

Dow Jones
·
Jun 18